Victor Mandel Net Worth

Victor Mandel biography

Victor E. Mandel is Independent Director of the Company. Mr. Mandel joined us as a director in August 2016 and previously served as a director of the Company from December 2015 until March 2016. He has over twenty-five years of experience in corporate strategy and corporate governance. Mr. Mandel previously served as Co-Chairman of Ambac Financial Group, Inc. (NASDAQ: AMBC) from May 2013 through December 2014 and as a director, chair of its Governance and Nominating Committee and member of its Audit and Strategy and Risk Policy Committees from May 2013 until May 2016. Additionally, he has previously served as a member of the board of directors and on the audit committees of Comsys IT Partners, Inc. (now a Manpower company), Broadpoint Gleacher Securities Group, Inc. (now Gleacher & Co., Inc.), and XLHealth Corp. (now a United Healthcare company). He previously served as the Chief Financial Officer of Circle.com (NASDAQ:CIRC) and served as Executive Vice President, Finance and Development of Snyder Communications, Inc. (NYSE:SNC) from 1999 to 2000. From 1991 to 1999, Mr. Mandel served as vice president in the Investment Research department at Goldman Sachs & Co. (NYSE:GS). Mr. Mandel holds an MBA in Finance from the Wharton School of Business at the University of Pennsylvania, an A.B. in Computer Science from Harvard University, and is a Chartered Financial Analyst.

How old is Victor Mandel?

Victor Mandel is 55, he's been the Independent Director of MYOS RENS Technology since 2016. There are 6 older and no younger executives at MYOS RENS Technology. The oldest executive at MYOS RENS Technology, Inc. is Christopher Dewey, 75, who is the Independent Director.

What's Victor Mandel's mailing address?

Victor's mailing address filed with the SEC is C/O MYOS RENS TECHNOLOGY INC., 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS, NJ, 07927.

Insiders trading at MYOS RENS Technology

Over the last 12 years, insiders at MYOS RENS Technology have traded over $0 worth of MYOS RENS Technology stock and bought 2,115,845 units worth $2,654,259 . The most active insiders traders include David J Matlin, Christopher Pechock és Joseph Mannello. On average, MYOS RENS Technology executives and independent directors trade stock every 78 days with the average trade being worth of $59,361. The most recent stock trade was executed by Joseph Mannello on 31 March 2020, trading 16,529 units of MYOS stock currently worth $16,694.

What does MYOS RENS Technology do?

MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

MYOS RENS Technology executives and stock owners

MYOS RENS Technology executives and other stock owners filed with the SEC include:

• Joseph Mannello,
  Chief Executive Officer, Director
• Robert Hariri,
  Independent Chairman of the Board
• Eric Zaltas,
  Independent Director
• Andrew Ponte,
  Independent Director
• Christopher Pechock,
  Independent Director
• Victor Mandel,
  Independent Director
• Christopher Dewey,
  Independent Director
• Louis Aronne,
  Independent Director
• Ren Ren,
  Director
• Sapna Srivastava,
  Director
• Joseph Dos Santos,
  Chief Financial Officer
• Kenrick Bryce Toussaint,
  Chief Executive Officer
• Buzz Aldrin,
  Director
• Zhengguang Lyu,
  Director
• Robert C. Jr. Ashton,
  Chief Medical Officer
• Peter Diamandis,
  Director
• John Craig Venter,
  Director
• Peter Levy,
  COO & Executive VP
• John Nosta,
  Director
• Carl De Freitas,
  Interim CFO
• Glen R. Fleischer,
  Chief Executive Officer
• David J Matlin,
  10% owner